Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Glenn W. Welling And Engaged Capital Reveal 4.7% Stake In Oplink Communications, Inc (OPLK); Enter Into Agreement With Voce Capital LLC To Go Activist On The Stock

Glenn W. Welling and his fund, Engaged Capital, have made a new addition to their equity portfolio: Oplink Communications, Inc (NASDAQ:OPLK). According to a recent filing with the Securities and Exchange Commission, Engaged Capital has acquired approximately 863,500 shares or 4.7% of the common stock. The fund has also entered an agreement with Voce Capital LLC and its manager, J. Daniel Plants, to go activist on Oplink Communications, Inc (NASDAQ:OPLK). Welling and Plants have pledged to discuss operating results and costs with the management of the company and to also look for ways to increase shareholder value.

Oplink Communications, Inc (NASDAQ:OPLK)

Chuck Royce also likes Oplink Communications, Inc (NASDAQ:OPLK) and has increased his fund’s holding of the stock by 4% during the first quarter of 2014. His fund, Royce & Associates, has reported ownership of approximately 1.12 million shares in its latest 13F filing. John W. Rogers and Ariel Investments are also bullish on this stock and have boosted their stake by 210% taking it to 1.07 million shares. John Overdeck and David Siegel, on the other hand, have reduced their exposure to Oplink Communications, Inc (NASDAQ:OPLK) by 1%, leaving their fund, Two Sigma Advisors, with approximately 51,400 shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!